Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More
Financial markets are holding their breath as the highly anticipated August 2025 Consumer Price Index (CPI) report looms, a critical barometer for inflation and a potential swing factor for the Federal Reserve's monetary policy. With inflation stubbornly hovering near the 3% mark, this economic data release, scheduled for Thursday, September
Johnson & Johnson (NYSE: JNJ) announced today that John Morikis, retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, has been elected to its Board of Directors.
Johnson & Johnson (NYSE: JNJ) will present at the Bernstein 2nd Annual Healthcare Forum on Wednesday, September 24th, 2025. Management will participate in a Fireside Chat at 1:10 p.m. Eastern Time.
Despite widespread market expectations for a September interest rate cut, the Federal Reserve finds itself navigating a perilous economic landscape marked by persistently high inflation. Stubbornly "sticky" services inflation, coupled with the escalating impact of new tariffs on core goods, is creating a complex dilemma for policymakers. While a cooling
What does the future hold for Johnson & Johnson? In this episode, we break down the company's strengths, challenges, and what investors can expect moving forward.
Global equity markets are bracing for a particularly tumultuous September, historically known as a challenging month for investors, now compounded by a fresh wave of geopolitical and domestic policy uncertainties. New, steep tariffs levied by the United States on imports from key trading partners like India and Switzerland threaten to
The financial markets are currently gripped by a palpable sense of unease, as a perfect storm of economic data, geopolitical events, corporate earnings, and Federal Reserve policy decisions conspire to fuel an unprecedented surge in market volatility. Investors and analysts alike are grappling with a rapidly shifting landscape, where sudden
The S&P 500 index has repeatedly scaled new all-time highs in recent months, a testament to robust corporate earnings and an enduring wave of optimism, largely fueled by advancements in Artificial Intelligence. This remarkable ascent, however, has ignited a fervent debate among financial analysts: are we witnessing a healthy
The U.S. economy is facing a concerning outlook for late 2025, with the Organisation for Economic Co-operation and Development (OECD) sounding the alarm on a potential "stagflation-lite" scenario. This dual threat of slowing economic growth and persistently high inflation presents a formidable challenge, risking reduced purchasing power for consumers,
As the summer fades and financial professionals return to their desks, the specter of the "September Effect"—a historical tendency for stock markets to deliver their weakest performance of the year—looms large over global equities. For September 2025, this seasonal anomaly is amplified by a complex web of economic
Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 14th to review third-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Darren Snellgrove, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson’s executive team.
The U.S. stock market is once again sending signals of caution, as major indices experienced a notable pullback from their recent record highs in early September 2025. This downturn, following a robust August that saw all three major indices achieve their fourth consecutive month of gains, marks a pivot
A significant sector rotation is currently underway in equity markets, shifting investor capital away from the mega-cap technology stocks that dominated recent years towards more traditional value and cyclical segments. This trend, gaining significant momentum in 2025, sees sectors such as financial services, basic materials, healthcare, energy, and industrials outperforming,
Johnson & Johnson ended a Phase 2a study of nipocalimab in rheumatoid arthritis after no added benefit was seen, but remains confident in its market potential.
The global economic landscape remains deeply entrenched in a complex and often volatile trade conflict between the United States and China. What began in January 2018 as a series of targeted duties has escalated significantly through 2025, with both nations frequently adjusting and reinstating tariffs, creating a tangled web of
The global financial markets are currently navigating a tempest of elevated volatility and profound uncertainty, a landscape that has become the new normal for investors worldwide. From persistent geopolitical tensions to unpredictable policy shifts and evolving macroeconomic conditions, the confluence of these factors demands a re-evaluation of traditional investment strategies.
The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy consumption of AI data centers is putting unprecedented strain on power grids and catalyzing a new wave of investment across traditional and
The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty, the underlying currents suggest continued, albeit slower, economic expansion, particularly within the United States. Investors are keenly watching the interplay
